- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Factory Mutual Insurance Co. Decreases AbbVie Stock Position
Institutional investor reduces stake in pharmaceutical company by over 20%
Apr. 11, 2026 at 8:38am
Got story updates? Submit your updates here. ›
A filing revealing a major institutional investor's reduced stake in a leading pharmaceutical company reflects the nuanced financial forces shaping the healthcare sector.North Chicago TodayFactory Mutual Insurance Co. lowered its stake in AbbVie Inc. (NYSE:ABBV) by 20.6% during the 4th quarter, according to a recent SEC filing. The firm sold 48,150 shares, leaving it with 185,150 shares worth $42.3 million as of the end of 2025.
Why it matters
This filing provides insight into the investment decisions of a major institutional investor and could signal broader market sentiment around AbbVie's stock performance and outlook.
The details
Factory Mutual Insurance Co. is a large property and casualty insurance provider that invests its premiums and reserves in various financial instruments, including stocks. The firm's reduced position in AbbVie may indicate a shift in its assessment of the pharmaceutical company's prospects.
- The stock sale occurred during the 4th quarter of 2025.
The players
Factory Mutual Insurance Co.
A major property and casualty insurance provider that invests its assets in various financial instruments, including stocks.
AbbVie Inc.
A global biopharmaceutical company that focuses on discovering, developing, and commercializing therapies for complex and chronic medical conditions.
The takeaway
This filing highlights the ongoing scrutiny and shifting sentiment around pharmaceutical stocks as investors assess factors like pipeline development, regulatory changes, and market competition.
